Cystic Fibrosis Weekly Update

Contents:

Phase 2a Trial Will Test Molgradex in CF Patients with NTM Infections

Apr 03, 2019 07:00 am | Santiago Gisler

Savara Pharmaceuticals has launched a Phase 2a clinical study to evaluate the effectiveness of Molgradex in cystic fibrosis (CF) patients with chronic nontuberculous mycobacterial (NTM) lung infections. Molgradex is an inhaled form of artificially produced human protein granulocyte-macrophage colony-stimulating factor (GM-CSF), which normally is produced and secreted by several types of immune cells to trigger a […]
The post Phase 2a Trial Will Test Molgradex in CF Patients with NTM Infections appeared first on Cystic Fibrosis News Today.

The Scenes in ‘Five Feet Apart’ that Tore My Heart

Apr 02, 2019 09:00 am | Brad Dell

Heard enough about “Five Feet Apart” yet? I know you’re begging to read just one more piece about it, right? I saw the movie about a week after its release and wasn’t planning to write about it. Certainly not about how ethically (and cinematically) good or bad the movie was. Our community has kicked that […]
The post The Scenes in ‘Five Feet Apart’ that Tore My Heart appeared first on Cystic Fibrosis News Today.

Virus that Infects Bacteria Turns Immune Response Away from P. aeruginosa, Study Shows

Apr 02, 2019 08:00 am | Patricia Inacio, PhD

Pseudomonas aeruginosa, the most common bacteria found in cystic fibrosis (CF) patients, uses a virus to go unnoticed by the host immune system, a new study shows. Treatment with a vaccine designed to help the immune system detect the virus was found to significantly reduce P. aeruginosa’s ability to infect mice, suggesting it might represent a new […]
The post Virus that Infects Bacteria Turns Immune Response Away from P. aeruginosa, Study Shows appeared first on Cystic Fibrosis News Today.